Treatment optimization of HBeAg-negative chronic viral hepatitis B with thymosin-α1

Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2010, Vol 27, Issue 4

Abstract

Chronic hepatitis B virus (HBV) infection is a widely prevalent and clinically significant condition with profound implications for health care costs worldwide. Interferon-α and direct antiviral nucleos(t)ide analogs such as lamivudine, entecavir, adefovir, telbivudine, tenofovir and clevudine, are effective in the therapy of chronic HBV infection, but efficacy is still found wanting, particularly in HBeAg-negative/anti-HBe-positive cases and in patients with lower levels of alanine aminotransferase. Well documented evidence supports the pivotal role of immunomodulation in the control of hepatitis B virus infection. Thymosin-α1, a 28-amino acid peptide derived from the amino end of the highly acidic protein prothymosin-α, is an immunomodulatory agent known to increase natural killer (NK), CD4 and CD8 cell counts, shift the immune response towards Th1 cells, increase MHC class I expression on virus infected cells, and inhibit viral replication by direct antiviral action. A differential cellular response has been observed within a range of prothymosin-α concentrations, and optimal concentrations associated with maximal response have been observed. These attributes of the parent molecule prothymosin-α can be assumed to be shared by thymosin-α1. Treatment of patients with chronic HBV infection with thymosin-α1, either alone or in combination with interferon-α, has yielded promising results. It is postulated that these results can be significantly improved by optimizing the dose of thymosin-α1 for individual patients to induce a maximum immunomodulatory response. Drug optimization will be determined by testing the mixed lymphocyte response of each patient to different doses of thymosin-α1, before the initiation of treatment.

Authors and Affiliations

G. HATZIS, O. TSOLAS

Keywords

Related Articles

Uremic stomatitis

No abstract available

Female sexual response models

The recent development of the field of sexual medicine has necessitated the understanding of how women are motivated and function sexually. The term "sexual response cycle" refers to a model that depicts sexual function...

Rheumatic manifestations in HIV-infected patients

Various rheumatic manifestations may develop in HIV-infected patients. In the musculoskeletal system the main conditions which have been reported are reactive, psoriatic or rheumatoid-like arthritis, gout, infective arth...

Stratified analysis of data

Stratified analysis or stratification is used to study and control for the effect of other than variables exposure and disease, in data analysis. Stratification means that the data are separated into categories or strat...

Clinical, classical and molecular genetics of 21-hydroxylase deficiency<br /> Current concepts

Congenital adrenal hyperplasia due to deficiency of the enzyme 21-hydroxylase (21-OH) is divided into the classical and non-classical forms. It is one of the most common autosomal recessive inherited diseases in humans....

Download PDF file
  • EP ID EP107845
  • DOI -
  • Views 70
  • Downloads 0

How To Cite

G. HATZIS, O. TSOLAS (2010). Treatment optimization of HBeAg-negative chronic viral hepatitis B with thymosin-α1 . Αρχεία Ελληνικής Ιατρικής, 27(4), 594-598. https://europub.co.uk/articles/-A-107845